000			02146 a2200601 4500
005			20250515182812.0
264		0	_c20090827
008			200908s 0 0 eng d
022			_a1533-4406
024	7		_a10.1056/NEJMoa0809003 _2doi
040			_aNLM _beng _cNLM
100	1		_aSmith, Matthew R
245	0	0	_aDenosumab in men receiving androgen-deprivation therapy for prostate cancer. _h[electronic resource]
260			_bThe New England journal of medicine _cAug 2009
300			_a745-55 p. _bdigital
500			_aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAndrogen Antagonists _xadverse effects
650	0	4	_aAntibodies, Monoclonal _xadverse effects
650	0	4	_aAntibodies, Monoclonal, Humanized
650	0	4	_aBone Density _xdrug effects
650	0	4	_aBone Density Conservation Agents _xadverse effects
650	0	4	_aBone Remodeling _xdrug effects
650	0	4	_aDenosumab
650	0	4	_aDouble-Blind Method
650	0	4	_aFractures, Bone _xepidemiology
650	0	4	_aGonadotropin-Releasing Hormone _xagonists
650	0	4	_aHumans
650	0	4	_aIncidence
650	0	4	_aInjections, Subcutaneous
650	0	4	_aLumbar Vertebrae _xdrug effects
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aOrchiectomy
650	0	4	_aOsteoporosis _xchemically induced
650	0	4	_aProstatic Neoplasms _xdrug therapy
650	0	4	_aRANK Ligand _xadverse effects
650	0	4	_aSpinal Fractures _xepidemiology
700	1		_aEgerdie, Blair
700	1		_aHernández Toriz, Narciso
700	1		_aFeldman, Robert
700	1		_aTammela, Teuvo L J
700	1		_aSaad, Fred
700	1		_aHeracek, Jiri
700	1		_aSzwedowski, Maciej
700	1		_aKe, Chunlei
700	1		_aKupic, Amy
700	1		_aLeder, Benjamin Z
700	1		_aGoessl, Carsten
773	0		_tThe New England journal of medicine _gvol. 361 _gno. 8 _gp. 745-55
856	4	0	_uhttps://doi.org/10.1056/NEJMoa0809003 _zAvailable from publisher's website
999			_c19077669 _d19077669